Daiichi Sankyo: Pressing The ADC Case Further, Not Being Felt By The Market

I have been sanguine on the prospects of the Daiichi Sankyo ( DSKYF ) ( DSNKY ) investment thesis, reiterating a "Buy" sentiment last September that has not returned gangbusters, in part due to setbacks in lungI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of inv ...